Search results
AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program
FierceBiotech· 3 days agoAltruBio has roared back after another pivot in its twisty history, securing up to $225 million in series B funding to take an immune checkpoint enhancer through a midphase ulcerative colitis ...
Johnson & Johnson (NYSE:JNJ) Shares Bought by BI Asset Management Fondsmaeglerselskab A S
ETF DAILY NEWS· 3 days agoBI Asset Management Fondsmaeglerselskab A S lifted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 59.0% in the 4th quarter, according to the company in its most recent 13F filing ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 2 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 1 day agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...
Securian Asset Management Inc. Sells 20,342 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoSecurian Asset Management Inc. lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.8% during the fourth quarter, according to the company in its most recent Form 13F filing ...
Marathon Capital Management Has $4.48 Million Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoMarathon Capital Management grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent disclosure with ...
Independent Advisor Alliance Has $23.59 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoIndependent Advisor Alliance decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange ...
Norges Bank Purchases New Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoJohnson & Johnson comprises 0.7% of Norges Bank’s investment portfolio, making the stock its 18th largest position. Other hedge funds and other institutional investors also recently modified ...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...